Details of the BTS
| General Information of Binding Target of SBP (BTS) (ID: ST00090) | ||||||
|---|---|---|---|---|---|---|
| BTS Name |
Carcinoembryonic antigen
|
|||||
| Synonyms |
Fragment
|
|||||
| BTS Type |
Protein
|
|||||
| Gene Name |
CEA
|
|||||
| Organism |
Homo sapiens (Human)
|
|||||
| UniProt ID | ||||||
| UniProt Entry | ||||||
| PFam | ||||||
| Sequence |
MGPPSAPPCRLHVPWKEVLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLAHNLPQ
NRIGYSWYKGERVDGNSLIVGYVIGTQQATPGPAYSGRETIYPNASLLIQNVTQNDTGFY TLQVIKSDLVNEEATGQFHVY |
|||||
| Sequence Length |
141
|
|||||
| Synthetic Binding Protein (SBP) Targeting This BTS |
|---|
| SBP Name | Highest Status | Mechanism | Affinity | Application | Details | Ref |
|---|---|---|---|---|---|---|
| BiTE AMG-211 | Phase I; Discontinued | Stimulator | N.A. | GI adenocarcinoma [ICD-11: 2D40] | [1], [2] | |
| Diabody anti-CEA T84.66 | Research | Binder | N.A. | Tools for rapid tumor targeting | [3], [4] | |
| Diabody anti-CEA x anti-CD3 | Research | Binder | N.A. | Cancers [ICD-11: 2D4Z] | [5] | |
| scFv anti-CEA HBA11 | Research | Binder | Kd: 2.8 nM | Immunotherapy | [6] | |
| scFv anti-CEA HBB11 | Research | Binder | Kd: 2 nM | Immunotherapy | [6] | |
| scFv anti-CEA HBB6 | Research | Binder | Kd: 7.1 nM | Immunotherapy | [6] | |
| scFv anti-CEA LOE17 | Research | Binder | Kd: 1 nM | Immunotherapy | [6] | |
| scFv anti-CEA LOSC2 | Research | Binder | Kd: 9 nM | Immunotherapy | [6] | |
| scFv anti-CEA T06D10 | Research | Binder | Kd: 1.4 nM | Immunotherapy | [6] | |
| References |
|---|